Women In Oncology

In this edition, disparities among women in the surgical workforce, GSK withdraws belantamab mafodotin from US market, risk for lymphoma low after postmastectomy reconstruction, and more.

More women surgeon scientists received NIH funding in 2020 than in 2010, but disparities remained in the proportion of women in the surgical workforce compared with those funded by the NIH, according to a study published in JAMA Surgery.

Women oncologists reported encountering difficult career choices and discriminatory practices when planning for a family, according to survey results published in JAMA Network Open.

After immigrating to the U.S. from India as a teenager, Deepa R. Halaharvi, DO, knew that she wanted to become a physician.

The basic science discoveries to which Helen E. Heslop, MD, DSc (Hon), has contributed place her firmly on the Mount Rushmore of pioneers in the field of gene and cell therapy.

Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine has appointed Sophia George, PhD, as the first-ever associate director of diversity, equity and inclusion.

As a nurse, Brianne “Bree” Duncan, RN, BSN, has always had the goal to help and make a difference in her patients’ lives.

Jessi Gold, MD MS, does not consider “OK” or “fine” to be emotions.

Nina Bhardwaj, MD, PhD, has spent her career investigating dendritic cells and identifying novel cancer-specific antigens with the goal of developing an off-the-shelf vaccine for treatment, work that has recently garnered recognition.

CHICAGO — “Women leaders are disproportionately doing the [invisible] work to make the company be better, and we need to do better for our women,” Shikha Jain, MD, FACP said here.